Learn More
Apexbio Technology LLC Cabozantinib (XL184, BMS-907351), 25mg. Cas: 849217-68-1 MFCD: MFCD20926324. VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor

Supplier: Apexbio Technology LLC A297725
Cabozantinib (also called XL184, BMS-907351 Cometriq [1]), is an inhibitor of multiple receptor tyrosine kinases (RTKs), including vascular endothelial growth factor receptor 2 (VEGFR2), hepatocyte growth factor receptor (MET), and rearranged during transfection (RET) [2] [3]. Other sizes are available. Please inqury us for quote.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.